Skip to content

Calculated risk score for identifying the complications of type 2 diabetes mellitus

Evaluation between serum uric acid to high-density lipoprotein cholesterol ratio and insulin resistance in type 2 diabetes patients - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/07/071563
Enrollment
116
Registered
2024-07-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Not applicable: Not applicable Control Intervention1: Not applicable: Not applicable

Sponsors

Dr. Pooja Singh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Based on the duration of T2DM, cases will be sub-grouped into a study group with less than 5 years of T2DM and a study group with 5-10 years of T2DM. CRP values less than 16 mg/L

Exclusion criteria

Exclusion criteria: 1. Age: less than 20 years and more than 60 years 2. Women with gestational diabetes and pregnant and lactating mothers. 3. Patients with Type 1 diabetes, hyperuricemia patients under medications, thyroid disorders, K/C/O CVD and other major illnesses [HTN, cancer, CKD] 4. T2DM patients with CRP more than16 mg/L

Design outcomes

Primary

MeasureTime frame
The study will be helpful in finding the association between demographical data, FBS, PPBS, HbA1C, SUA, lipid profile, and UHR, which can be used to assess insulin resistance for further managing type 2 diabetes mellitus. Publications will be done in International / National journals with a high impact factor. Timepoint: At the end of the study after patient recruitment

Secondary

MeasureTime frame
Evaluation of Comorbidities: Assessing the prevalence and impact of other health conditions (e.g., hypertension, cardiovascular diseases, renal function) in patients with type 2 diabetes mellitus.Timepoint: In the end of the study

Countries

India

Contacts

Public ContactDr Pooja Singh

Kasturba medical college

drpoojasingh0990@gmail.com8076130822

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026